- Home
- APYX vs INCR Comparison
APYX vs INCR Comparison
Compare APYX & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- INCR
- Stock Information
- Founded
- APYX 1982
- INCR 1994
- Country
- APYX United States
- INCR Israel
- Employees
- APYX N/A
- INCR N/A
- Industry
- APYX Medical/Dental Instruments
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- INCR Health Care
- Exchange
- APYX Nasdaq
- INCR Nasdaq
- Market Cap
- APYX 84.7M
- INCR 84.5M
- IPO Year
- APYX 1987
- INCR N/A
- Fundamental
- Price
- APYX $2.15
- INCR $1.55
- Analyst Decision
- APYX Hold
- INCR
- Analyst Count
- APYX 2
- INCR 0
- Target Price
- APYX N/A
- INCR N/A
- AVG Volume (30 Days)
- APYX 96.0K
- INCR 24.4K
- Earning Date
- APYX 08-07-2025
- INCR 08-15-2025
- Dividend Yield
- APYX N/A
- INCR N/A
- EPS Growth
- APYX N/A
- INCR N/A
- EPS
- APYX N/A
- INCR N/A
- Revenue
- APYX $47,288,000.00
- INCR $65,575,323.00
- Revenue This Year
- APYX $2.25
- INCR $69.54
- Revenue Next Year
- APYX $6.76
- INCR $41.75
- P/E Ratio
- APYX N/A
- INCR N/A
- Revenue Growth
- APYX N/A
- INCR N/A
- 52 Week Low
- APYX $0.76
- INCR $1.17
- 52 Week High
- APYX $2.73
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- APYX 54.50
- INCR 60.11
- Support Level
- APYX $2.12
- INCR $1.48
- Resistance Level
- APYX $2.73
- INCR $1.56
- Average True Range (ATR)
- APYX 0.26
- INCR 0.06
- MACD
- APYX -0.00
- INCR 0.01
- Stochastic Oscillator
- APYX 40.63
- INCR 80.99
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.